Daré Bioscience, Inc. DARE

$DARE beautiful short.

Pharmaceutical Company are always volatile but I believe Dare has a lot of potential. I wish they would do a better job promoting there product.

A little good news every week.

I am very sure that there will be a buy offer soon from big pharmaceutical company

Dare waiting for earnings report next week.

Dare is going up nice and steady not to wake up the bears that are sleeping.

You can’t announce something before the deals are done.

Useless CEO

Dare Bioscience Stock (NASDAQ:DARE), Analyst Ratings, Price Targets, Predictions
Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$6.00
Consensus Price Target1
$7.88
Analyst Rating Summary1
Buy Overweight Hold Underweight Sell 4 0 0 0 0
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JonesTrading
Roth Capital
Brookline Capital

1calculated from analyst ratings published within the last 3 years
ANALYST RATINGS FOR DARE BIOSCIENCE
All Ratings (7)
Upgrades (0)
Downgrades (0)
Initiations (3)
Premium Tools & Ideas

Date
Upside/Downside
Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/31/2023 621.28% HC Wainwright & Co. → $7 Reiterates → Buy Get Alert
12/13/2022 621.28% HC Wainwright & Co. $6 → $7 Maintains Buy Get Alert
12/01/2022 518.24% JonesTrading → $6 Initiates → Buy Get Alert
04/01/2022 518.24% HC Wainwright & Co. $5 → $6 Maintains Buy Get Alert
06/30/2021 1033.44% Roth Capital $9 → $11 Maintains Buy Get Alert
12/18/2020 415.2% HC Wainwright & Co. → $5 Initiates → Buy Get Alert
04/28/2020 672.8% Brookline Capital

Analyst Forecast
According to 12 analysts, the average rating for DARE stock is "Buy." The 12-month stock price forecast is $6.12, which is an increase of 530.86% from the latest price.

Price Target
$6.12
(530.86% upside)
Analyst Consensus: Buy

Strong​Sell
Sell
Hold
Buy
Strong​Buy
0
5
10